NovaBay Pharmaceuticals, Inc. Equity Repurchase (Preffered, Net)

Equity Repurchase (Preffered, Net) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Equity Repurchase (Preffered, Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Equity Repurchase (Preffered, Net) for the quarter ending December 31, 2021 was $14.9 Million (a Infinity% increase compared to previous quarter)
  • Annual Equity Repurchase (Preffered, Net) for 2021 was $14.9 Million (a 473.83% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Equity Repurchase (Preffered, Net) of NovaBay Pharmaceuticals, Inc.

Most recent Equity Repurchase (Preffered, Net)of NBY including historical data for past 10 years.

Interactive Chart of Equity Repurchase (Preffered, Net) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Equity Repurchase (Preffered, Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $14.91 $14.91
2019 $0.0 $2.6 $2.6

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology